Exchange: NYSE·Updated 09:01 AM EDT
ABBV logo

ABBV Abbvie Inc

$262.60
$0.88
(0.34%)
Pre-Market
Prev Close $261.72
EarningsOct 29
Mkt Cap$462.49B
Vol13,896.00

About ABBV

AbbVie, Inc. is a research-based biopharmaceutical company, which engages in the development and sale of pharmaceutical products. It focuses on treating conditions such as chronic autoimmune diseases in rheumatology, gastroenterology, and dermatology, oncology, including blood cancers, virology, including hepatitis C virus (HCV) and human immunodeficiency virus (HIV), neurological disorders such as Parkinson’s disease, metabolic disorders, including thyroid disease and complications associated with cystic fibrosis, pain associated with endometriosis, and other serious health conditions. The company was founded on October 19, 2011 and is headquartered in North Chicago, IL.
58

Bullish Sentiment

How do you feel about ABBV?

Advertisement|Remove ads.